Advanced
  Home Compare Reports

Comparison with Similar Reports

Medical Device Connectivity Market by Product & Services (Integration Solutions, Telemetry, Connectivity Hubs), Technology (Wired, Hybrid), Applicatio...

Publisher:        MarketsandMarkets

# of Pages:        292

Rating: 

1 User License $4,950

Publication Date:  July, 2021

Price:       $4,950 / User License




1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION & SCOPE 35
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 36
1.2.2 MARKET SEGMENTATION 36
FIGURE 1 MEDICAL DEVICE CONNECTIVITY MARKET SEGMENTATION 36
1.2.3 YEARS CONSIDERED FOR THE STUDY 37
1.3 CURRENCY 37
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 37
1.4 STAKEHOLDERS 38
1.5 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
2.2 RESEARCH METHODOLOGY DESIGN 40
FIGURE 2 MEDICAL DEVICE CONNECTIVITY MARKET: RESEARCH DESIGN 40
2.2.1 SECONDARY RESEARCH 41
2.2.1.1 Key data from secondary sources 42
2.2.2 PRIMARY DATA 43
2.2.2.1 Primary sources 43
2.2.2.2 Key data from primary sources 44
2.2.2.3 Insights from primary experts 45
2.2.2.4 Breakdown of primary interviews: supply-side and demand-side participants 45
2.3 MARKET SIZE ESTIMATION: MEDICAL DEVICE CONNECTIVITY MARKET 46
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 46
FIGURE 4 REVENUE SHARE ANALYSIS ILLUSTRATION 47
FIGURE 5 TOP-DOWN APPROACH 48
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MEDICAL DEVICE CONNECTIVITY MARKET (2021–2026) 49
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 51
FIGURE 8 DATA TRIANGULATION METHODOLOGY 51
2.5 MARKET SHARE ESTIMATION 51
2.6 ASSUMPTIONS FOR THE STUDY 52
2.7 LIMITATIONS 52
2.7.1 METHODOLOGY-RELATED LIMITATIONS 52
2.7.2 SCOPE-RELATED LIMITATIONS 52
2.8 RISK ASSESSMENT 53
TABLE 2 RISK ASSESSMENT: MEDICAL DEVICE CONNECTIVITY MARKET 53
3 EXECUTIVE SUMMARY 54
FIGURE 9 MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION) 54
FIGURE 10 MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 55
FIGURE 11 MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 56
FIGURE 12 MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 57
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE MEDICAL DEVICE CONNECTIVITY MARKET 58
4 PREMIUM INSIGHTS 59
4.1 MEDICAL DEVICE CONNECTIVITY MARKET OVERVIEW 59
FIGURE 14 GROWING NUMBER OF COVID-19 CASES AND THE NEED FOR CONTINUOUS PATIENT MONITORING TO DRIVE MARKET GROWTH 59
4.2 ASIA PACIFIC: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER AND COUNTRY (2020) 60
FIGURE 15 HOSPITALS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020 60
4.3 MEDICAL DEVICE CONNECTIVITY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 16 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 61
4.4 MEDICAL DEVICE CONNECTIVITY MARKET, BY REGION (2019–2026) 62
FIGURE 17 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MEDICAL DEVICE CONNECTIVITY MARKET DURING THE FORECAST PERIOD 62
4.5 MEDICAL DEVICE CONNECTIVITY MARKET: DEVELOPED VS. DEVELOPING MARKETS 62
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
TABLE 3 MARKET DYNAMICS: MEDICAL DEVICE CONNECTIVITY MARKET 63
5.2.1 MARKET DRIVERS 64
5.2.1.1 Growing global prevalence of COVID-19 64
TABLE 4 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION
(AS OF JUNE 28, 2021) 65
5.2.1.2 Increasing penetration of EHRs & health information exchange systems in healthcare organizations 65
5.2.1.3 Cost benefits of connected healthcare environments vis-à-vis rising healthcare expenditures 66
FIGURE 19 CURRENT EXPENDITURE ON HEALTH (2019) 67
5.2.1.4 Increasing integration of medical devices with hospital information systems 68
5.2.1.5 Favorable government support and initiatives 68
5.2.1.6 Growing focus on care quality and patient safety 69
5.2.1.7 Medical device connectivity aids in data analytics 70
5.2.1.8 Growing investments to improve healthcare infrastructures 71
5.2.2 MARKET RESTRAINTS 72
5.2.2.1 High cost of deployment for small healthcare organizations 72
5.2.2.2 Reluctance of medical professionals to adopt advanced healthcare IT solutions 72
5.2.3 MARKET OPPORTUNITIES 73
5.2.3.1 Increasing consolidation in the healthcare industry 73
FIGURE 20 US: HOSPITAL MERGERS & ACQUISITIONS, 2015-2019 73
5.2.3.2 Growing inclination towards home healthcare 74
5.2.3.3 Growing telehealth and remote patient monitoring markets 74
5.2.3.4 Emerging markets 75
5.2.4 MARKET CHALLENGES 76
5.2.4.1 Integration between various hospital information systems and medical devices 76
5.2.4.2 Data security concerns 76
5.2.4.3 Lack of skilled healthcare IT professionals 77
6 INDUSTRY INSIGHTS 78
6.1 INTRODUCTION 78
6.2 INDUSTRY TRENDS 78
6.2.1 SHIFT TOWARDS CLOUD-BASED SOLUTIONS 78
6.2.2 INTEGRATION OF MEDICAL DEVICE DATA INTO CARE DELIVERY PROCESSES 79
6.2.3 GROWING NEED FOR SEMANTIC INTEROPERABILITY THROUGH MEDICAL DEVICE CONNECTIVITY SOLUTIONS 79
6.2.4 TRANSITION OF POC DIAGNOSTICS FROM HOSPITALS TO HOME SETTINGS 80
6.2.5 GROWING ADOPTION OF TELEHEALTH SOLUTIONS 80
6.2.6 SHIFT FROM PAYMENT-FOR-PERFORMANCE TO PAYMENT-FOR-OUTCOMES MODELS IS BOOSTING THE DEMAND FOR MEDICAL DEVICE CONNECTIVITY SOLUTIONS 80
6.2.7 M2M COMMUNICATIONS & ARTIFICIAL INTELLIGENCE BOOM IN HEALTHCARE 81
6.2.8 LOW-POWER CONNECTIVITY SOLUTIONS & ADVANCEMENTS IN SOFTWARE ARCHITECTURE 82
6.3 REGULATORY ANALYSIS 82
TABLE 5 KEY REGULATIONS & STANDARDS GOVERNING MEDICAL DEVICE CONNECTIVITY SOLUTIONS 84
6.4 INTEROPERABILITY STANDARDS 85
TABLE 6 KEY STANDARDS FOR INTEROPERABILITY IN THE DIGITAL HEALTH SPECTRUM 85
TABLE 7 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN THE DIGITAL HEALTH SPECTRUM 87
6.5 PRICING ANALYSIS 88
TABLE 8 PRICING MODEL: MEDICAL DEVICE CONNECTIVITY SOLUTIONS, BY TYPE 88
TABLE 9 PRICING MODEL: MEDICAL DEVICE CONNECTIVITY SOLUTIONS, BY REGION 88
6.6 ECOSYSTEM ANALYSIS 89
6.6.1 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS 89
6.6.2 MEDICAL DEVICE CONNECTIVITY MARKET: ECOSYSTEM ANALYSIS 90
6.7 PATENT ANALYSIS 90
6.7.1 PATENT PUBLICATION TRENDS FOR MEDICAL DEVICE CONNECTIVITY 90
FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2021) 91
6.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 91
FIGURE 22 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL DEVICE CONNECTIVITY PATENTS (JANUARY 2011–JULY 2021) 92
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL DEVICE CONNECTIVITY PATENTS (JANUARY 2011–JULY 2021) 92
TABLE 10 LIST OF PATENTS/PATENT APPLICATIONS IN THE MEDICAL DEVICE CONNECTIVITY MARKET, 2020–2021 93
6.8 IMPACT OF COVID-19 ON THE MEDICAL DEVICE CONNECTIVITY MARKET 94
7 MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE 97
7.1 INTRODUCTION 98
TABLE 11 MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 98
7.2 MEDICAL DEVICE CONNECTIVITY SOLUTIONS 99
FIGURE 24 MEDICAL DEVICE INTEGRATION SOLUTIONS DOMINATED THE MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET IN 2020 100
TABLE 12 MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 13 MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
7.2.1 MEDICAL DEVICE INTEGRATION SOLUTIONS 101
7.2.1.1 Increasing demand for EHR implementation and the need for accurate patient information to drive the adoption of integration solutions 101
TABLE 14 MEDICAL DEVICE INTEGRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS 102
TABLE 15 MEDICAL DEVICE INTEGRATION SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
7.2.2 TELEMETRY SYSTEMS 103
7.2.2.1 Rising demand for remote patient monitoring to drive the adoption of telemetry systems 103
TABLE 16 TELEMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS 104
TABLE 17 TELEMETRY SYSTEMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
7.2.3 CONNECTIVITY HUBS 105
7.2.3.1 Growing demand for remote patient monitoring and the need to simplify workflows in healthcare settings are supporting the growth of this market 105
TABLE 18 CONNECTIVITY HUBS OFFERED BY KEY MARKET PLAYERS 106
TABLE 19 CONNECTIVITY HUBS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
7.2.4 INTERFACE DEVICES 107
7.2.4.1 Rising importance of health information exchange and EHR implementation within healthcare organizations to support market growth 107
TABLE 20 INTERFACE DEVICES OFFERED BY KEY MARKET PLAYERS 107
TABLE 21 INTERFACE DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 108
7.3 MEDICAL DEVICE CONNECTIVITY SERVICES 108
FIGURE 25 SUPPORT & MAINTENANCE SERVICES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 109
TABLE 22 MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 23 MEDICAL DEVICES CONNECTIVITY SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
7.3.1 SUPPORT & MAINTENANCE SERVICES 110
7.3.1.1 Growing trend of outsourcing of healthcare IT support and services is driving the growth of this market 110
TABLE 24 SUPPORT & MAINTENANCE SERVICES OFFERED BY KEY MARKET PLAYERS 111
TABLE 25 MEDICA DEVICE CONNECTIVITY MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY COUNTRY, 2019–2026 (USD MILLION) 111
7.3.2 IMPLEMENTATION & INTEGRATION SERVICES 112
7.3.2.1 Requirement of software interoperability and the need to comply with regulatory standards to boost the market growth 112
TABLE 26 IMPLEMENTATION & INTEGRATION SERVICES OFFERED BY KEY MARKET PLAYERS 112
TABLE 27 MEDICAL DEVICE CONNECTIVITY MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY COUNTRY, 2019–2026 (USD MILLION) 113
7.3.3 TRAINING SERVICES 113
7.3.3.1 Need to increase the adoption of healthcare IT solutions and to increase awareness of the latest medical device connectivity solutions available to boost the market growth 113
TABLE 28 TRAINING SERVICES OFFERED BY KEY MARKET PLAYERS 114
TABLE 29 MEDICAL DEVICE CONNECTIVITY MARKET FOR TRAINING SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 114
7.3.4 CONSULTING SERVICES 115
7.3.4.1 Consulting services guide healthcare providers in the implementation of medical device connectivity solutions—a key factor driving market growth 115
TABLE 30 CONSULTING SERVICES OFFERED BY KEY MARKET PLAYERS 115
TABLE 31 MEDICAL DEVICE CONNECTIVITY MARKET FOR CONSULTING SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 116
8 MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY 117
8.1 INTRODUCTION 118
TABLE 32 MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 118
8.2 WIRELESS TECHNOLOGIES 118
8.2.1 GROWING DEMAND FOR CONNECTED DEVICES AND GROWING TELEHEALTH INDUSTRY TO PROPEL MARKET GROWTH 118
TABLE 33 MEDICAL DEVICE CONNECTIVITY MARKET FOR WIRELESS TECHNOLOGIES,
BY COUNTRY, 2019–2026 (USD MILLION) 121
8.3 WIRED TECHNOLOGIES 121
8.3.1 WIRED TECHNOLOGIES ARE HIGHLY SECURE PLATFORMS FOR DATA TRANSFORMATION AND EXCHANGING IMAGING DATA—A KEY FACTOR SUPPORTING MARKET GROWTH 121
TABLE 34 MEDICAL DEVICE CONNECTIVITY MARKET FOR WIRED TECHNOLOGIES,
BY COUNTRY, 2019–2026 (USD MILLION) 123
8.4 HYBRID TECHNOLOGIES 123
8.4.1 INCREASING NEED FOR MOBILITY AND SAFETY ALONG WITH DATA SECURITY TO DRIVE THE DEMAND FOR HYBRID TECHNOLOGIES 123
TABLE 35 MEDICAL DEVICE CONNECTIVITY MARKET FOR HYBRID TECHNOLOGIES,
BY COUNTRY, 2019–2026 (USD MILLION) 124
9 MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION 125
9.1 INTRODUCTION 126
TABLE 36 MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 126
9.2 VITAL SIGNS & PATIENT MONITORS 126
9.2.1 INCREASING NEED FOR REMOTE PATIENT MONITORING TO INCREASE THE ADOPTION OF CONNECTIVITY SOLUTIONS ACROSS FACILITIES 126
TABLE 37 MEDICAL DEVICE CONNECTIVITY MARKET FOR VITAL SIGNS & PATIENT MONITORS, BY COUNTRY, 2019–2026 (USD MILLION) 128
9.3 ANESTHESIA MACHINES & VENTILATORS 128
9.3.1 THE OPERATIONAL ADVANTAGES OF ANESTHESIA MACHINES & VENTILATORS ARE THE KEY FACTORS DRIVING THIS MARKET 128
TABLE 38 MEDICAL DEVICE CONNECTIVITY MARKET FOR ANESTHESIA MACHINES & VENTILATORS, BY COUNTRY, 2019–2026 (USD MILLION) 130
9.4 INFUSION PUMPS 130
9.4.1 PUMP-EMR INTEROPERABILITY HAS WITNESSED INCREASED ADOPTION DURING IV THERAPY TO REDUCE MEDICATION ERRORS 130
TABLE 39 DEVELOPMENTS IN SMART PUMP-EMR INTEROPERABILITY 131
TABLE 40 MEDICAL DEVICE CONNECTIVITY MARKET FOR INFUSION PUMPS,
BY COUNTRY, 2019–2026 (USD MILLION) 132
9.5 OTHER APPLICATIONS 132
TABLE 41 MEDICAL DEVICE CONNECTIVITY MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 133
10 MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER 134
10.1 INTRODUCTION 135
TABLE 42 MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 135
10.2 HOSPITALS 135
10.2.1 INCREASING PATIENT VISITS DUE TO COVID-19 AND RISING PURCHASING POWER OF HOSPITALS ARE DRIVING THE ADOPTION OF MEDICAL DEVICE CONNECTIVITY SOLUTIONS 135
TABLE 43 MEDICAL DEVICE CONNECTIVITY MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 137
10.3 HOME HEALTHCARE CENTERS 137
10.3.1 GROWING BENEFITS AND ADOPTION OF TELEHEALTH SOLUTIONS ARE DRIVING MARKET GROWTH 137
TABLE 44 MEDICAL DEVICE CONNECTIVITY FOR HOME HEALTHCARE CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 139
10.4 AMBULATORY CARE CENTERS 139
10.4.1 RISING PATIENT VOLUME AT AMBULATORY CARE CENTERS IS DRIVING MARKET GROWTH 139
FIGURE 26 US: SURGICAL PROCEDURE VOLUME, BY SETTING: AMBULATORY SURGERY CENTERS VS. HOSPITALS (2005-2020) 140
TABLE 45 MEDICAL DEVICE CONNECTIVITY MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 141
10.5 DIAGNOSTIC & IMAGING CENTERS 141
10.5.1 GROWING VOLUME OF MEDICAL DATA & RISING DEMAND DUE TO TECHNOLOGICAL IMPROVEMENTS IN IMAGING ARE DRIVING MARKET GROWTH 141
TABLE 46 MEDICAL DEVICE CONNECTIVITY MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 142
11 MEDICAL DEVICE CONNECTIVITY MARKET, BY REGION 143
11.1 INTRODUCTION 144
FIGURE 27 MEDICAL DEVICE CONNECTIVITY MARKET: GEOGRAPHIC SNAPSHOT (2020) 144
TABLE 47 MEDICAL DEVICE CONNECTIVITY MARKET, BY REGION,
2019–2026 (USD MILLION) 145
11.2 IMPACT OF COVID-19 ON THE MEDICAL DEVICE CONNECTIVITY MARKET 145
11.3 NORTH AMERICA 146
FIGURE 28 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET SNAPSHOT 147
TABLE 48 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 147
TABLE 49 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 148
TABLE 50 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 51 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 52 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 149
TABLE 53 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 149
TABLE 54 NORTH AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER, 2019–2026 (USD MILLION) 149
11.3.1 US 150
11.3.1.1 Advanced medical infrastructure and increasing healthcare expenditure to drive the market growth 150
TABLE 55 US: KEY MACROINDICATORS 151
TABLE 56 US: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 151
TABLE 57 US: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 58 US: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 59 US: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 152
TABLE 60 US: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 152
TABLE 61 US: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 153
11.3.2 CANADA 153
11.3.2.1 Growing adoption of technologically advanced HCIT solutions to propel market growth in Canada 153
TABLE 62 CANADA: KEY MACROINDICATORS 154
TABLE 63 CANADA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 154
TABLE 64 CANADA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 65 CANADA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 66 CANADA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 155
TABLE 67 CANADA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 156
TABLE 68 CANADA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 156
11.4 EUROPE 156
TABLE 69 EUROPE: MEDICAL DEVICE CONNECTIVITY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 157
TABLE 70 EUROPE: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 158
TABLE 71 EUROPE: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 72 EUROPE: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 73 EUROPE: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 159
TABLE 74 EUROPE: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 159
TABLE 75 EUROPE: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 159
11.4.1 GERMANY 160
11.4.1.1 Increasing health expenditure and growing network of hospitals in the country to drive the adoption of connectivity solutions and services 160
TABLE 76 GERMANY: KEY MACROINDICATORS 160
TABLE 77 GERMANY: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 161
TABLE 78 GERMANY: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 79 GERMANY: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 80 GERMANY: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 162
TABLE 81 GERMANY: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 162
TABLE 82 GERMANY: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 162
11.4.2 FRANCE 163
11.4.2.1 High healthcare spending and favorable government initiatives to drive the demand for medical device connectivity solutions and services in France 163
TABLE 83 FRANCE: KEY MACROINDICATORS 164
TABLE 84 FRANCE: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 164
TABLE 85 FRANCE: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 86 FRANCE: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 87 FRANCE: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 165
TABLE 88 FRANCE: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 165
TABLE 89 FRANCE: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 166
11.4.3 UK 166
11.4.3.1 Rising geriatric population & government initiatives to drive the adoption of medical device connectivity solutions in the UK 166
TABLE 90 UK: KEY MACROINDICATORS 167
TABLE 91 UK: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 167
TABLE 92 UK: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 93 UK: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 168
TABLE 94 UK: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 168
TABLE 95 UK: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 169
TABLE 96 UK: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 169
11.4.4 ITALY 169
11.4.4.1 Increasing adoption eHealth technologies to propel market growth 169
TABLE 97 ITALY: KEY MACROINDICATORS 170
TABLE 98 ITALY: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 171
TABLE 99 ITALY: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 100 ITALY: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 101 ITALY: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 172
TABLE 102 ITALY: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 172
TABLE 103 ITALY: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 172
11.4.5 SPAIN 173
11.4.5.1 Focus on improving the healthcare infrastructure and growing number of COVID-19 cases to support the market growth 173
TABLE 104 SPAIN: KEY MACROINDICATORS 174
TABLE 105 SPAIN: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 174
TABLE 106 SPAIN: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 107 SPAIN: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 108 SPAIN: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 175
TABLE 109 SPAIN: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 175
TABLE 110 SPAIN: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 176
11.4.6 REST OF EUROPE 176
TABLE 111 ROE: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 177
TABLE 112 ROE: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 113 ROE: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 114 ROE: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 178
TABLE 115 ROE: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 178
TABLE 116 ROE: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 178
11.5 ASIA PACIFIC 179
FIGURE 29 APAC: MEDICAL DEVICE CONNECTIVITY MARKET SNAPSHOT 180
TABLE 117 APAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 181
TABLE 118 APAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 181
TABLE 119 APAC: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 120 APAC: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 121 APAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 182
TABLE 122 APAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 182
TABLE 123 APAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 183
11.5.1 JAPAN 183
11.5.1.1 Growing aging population in the country and focus towards improving the healthcare infrastructure to drive market growth 183
TABLE 124 JAPAN: KEY MACROINDICATORS 184
TABLE 125 JAPAN: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 184
TABLE 126 JAPAN: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 127 JAPAN: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 128 JAPAN: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 185
TABLE 129 JAPAN: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 186
TABLE 130 JAPAN: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 186
11.5.2 CHINA 186
11.5.2.1 Healthcare development in the country and large patient pool due to the COVID-19 pandemic to drive the adoption of medical device connectivity solutions 186
TABLE 131 CHINA: KEY MACROINDICATORS 187
TABLE 132 CHINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 187
TABLE 133 CHINA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 134 CHINA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 135 CHINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 188
TABLE 136 CHINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 189
TABLE 137 CHINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 189
11.5.3 INDIA 189
11.5.3.1 Increasing demand for healthcare IT solutions and growing investments in country’s healthcare infrastructure to support market growth 189
TABLE 138 INDIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 190
TABLE 139 INDIA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 140 INDIA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 141 INDIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 191
TABLE 142 INDIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 192
TABLE 143 INDIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 192
11.5.4 REST OF ASIA PACIFIC 192
TABLE 144 ROAPAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 193
TABLE 145 ROAPAC: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 146 ROAPAC: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 147 ROAPAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 194
TABLE 148 ROAPAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 195
TABLE 149 ROAPAC: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 195
11.6 LATIN AMERICA 195
TABLE 150 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 196
TABLE 151 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 196
TABLE 152 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 153 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 154 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 197
TABLE 155 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 197
TABLE 156 LATIN AMERICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER, 2019–2026 (USD MILLION) 198
11.6.1 BRAZIL 198
11.6.1.1 Growing emphasis on reducing healthcare costs is driving the adoption of medical device connectivity solutions 198
TABLE 157 BRAZIL: KEY MACROINDICATORS 199
TABLE 158 BRAZIL: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 199
TABLE 159 BRAZIL: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 160 BRAZIL: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 161 BRAZIL: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 200
TABLE 162 BRAZIL: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 201
TABLE 163 BRAZIL: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 201
11.6.2 MEXICO 201
11.6.2.1 Increasing demand and adoption of healthcare IT solutions to drive growth in the medical device connectivity market in Mexico 201
TABLE 164 MEXICO: KEY MACROINDICATORS 202
TABLE 165 MEXICO: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 202
TABLE 166 MEXICO: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 167 MEXICO: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 168 MEXICO: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 203
TABLE 169 MEXICO: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 204
TABLE 170 MEXICO: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 204
11.6.3 ARGENTINA 204
11.6.3.1 Rising demand for home care to drive the growth of the market in Argentina 204
TABLE 171 ARGENTINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 205
TABLE 172 ARGENTINA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 173 ARGENTINA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 174 ARGENTINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 206
TABLE 175 ARGENTINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 206
TABLE 176 ARGENTINA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER, 2019–2026 (USD MILLION) 207
11.6.4 REST OF LATIN AMERICA (ROLA) 207
TABLE 177 ROLA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 208
TABLE 178 ROLA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 208
TABLE 179 ROLA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 208
TABLE 180 ROLA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 209
TABLE 181 ROLA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 209
TABLE 182 ROLA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 209
11.7 MIDDLE EAST & AFRICA 210
TABLE 183 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY MARKET,
BY REGION, 2019–2026 (USD MILLION) 210
TABLE 184 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 211
TABLE 185 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 186 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 187 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION) 212
TABLE 188 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 212
TABLE 189 MIDDLE EAST & AFRICA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER, 2019–2026 (USD MILLION) 212
11.7.1 SAUDI ARABIA 213
11.7.1.1 Rising focus on expanding and improving the present health infrastructure will drive the demand for medical device connectivity solutions in the region 213
TABLE 190 SAUDI ARABIA: KEY MACROINDICATORS 213
TABLE 191 SAUDI ARABIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 213
TABLE 192 SAUDI ARABIA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 193 SAUDI ARABIA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 194 SAUDI ARABIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION) 214
TABLE 195 SAUDI ARABIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 215
TABLE 196 SAUDI ARABIA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER, 2019–2026 (USD MILLION) 215
11.7.2 REST OF MIDDLE EAST & AFRICA 215
TABLE 197 ROMEA: MEDICAL DEVICE CONNECTIVITY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 216
TABLE 198 ROMEA: MEDICAL DEVICE CONNECTIVITY SOLUTIONS MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 199 ROMEA: MEDICAL DEVICE CONNECTIVITY SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 200 ROMEA: MEDICAL DEVICE CONNECTIVITY MARKET, BY TECHNOLOGY,
2019–2026 (USD MILLION) 217
TABLE 201 ROMEA: MEDICAL DEVICE CONNECTIVITY MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 217
TABLE 202 ROMEA: MEDICAL DEVICE CONNECTIVITY MARKET, BY END USER,
2019–2026 (USD MILLION) 218

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127